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Comparison of 12-hour Urine and Protein:Creatinine Ratio to 24-hour Urine
for the Diagnosis of Preeclampsia
Christina Tun, MD1; Joanne Quiñones, MD, MSCE1; Anita Kurt, PhD1; John Smulian, MD, MPH1; Meredith Rochon, MD1
Abstract 
OBJECTIVE:  The standard threshold value of proteinuria in the setting of 
hypertension for the diagnosis of preeclampsia is a 24-hour urine protein (24-hr) ≥ 
300mg. Equivalent values have been generated for more convenient and/or cost-
effective tests, such as the 12-hour urine protein (12-hr) and protein:creatinine ratio 
(PCR), but these have not been tested prospectively. The purpose was to compare 
the performance of the 12-hr and PCR to a standard 24-hr ≥ 300mg for the diagnosis 
of preeclampsia.  
STUDY DESIGN:  This was a prospective observational study of women 
admitted to the Lehigh Valley Health Network from 7/1/2010 to 12/31/2011 for 
diagnosis and/or management of preeclampsia. For each patient, PCR, 12-hr and 
24-hr urine specimens were collected. Only the 24-hr result was used for clinical 
management. Test characteristics for identifying 24-hr ≥ 300mg were calculated. 
Cutoff values were based on previously published data. 
RESULTS:  A total of 102 patients were enrolled during the study period, 12 
of which were subsequently excluded (11 delivered prior to completion, 1 was 
excluded due to lab error) for a final cohort of 90 patients. Twenty-eight (31%) of 
the final cohort had 24-hr ≥ 300mg. Both 12-hr > 165mg and PCR > 0.15 correlate 
significantly with 24-hr ≥ 300mg (r=0.99, p<0.001 and r=0.54, p<0.001, respectively). 
Test characteristics for 12-hr > 165mg and PCR > 0.15 are shown in Table 3. 
CONCLUSION:  12-hr > 165mg performed well as a predictor of 24-hr ≥ 300mg, 
with the benefit of a shorter evaluation time. The high negative predictive value of 
PCR suggests that it may be most useful in identifying patients that do not have 
24-hr ≥ 300mg. Use of both these tests can be considered in the evaluation and 
management of patients with suspected preeclampsia. 
Background
Protein excretion is variable in the setting of preeclampsia, therefore it is 
recommended that a 24-hour urine be used for the diagnosis (1-3). Other 
tests for the diagnosis of preeclampsia have been proposed, including 
12-hour urine protein > 165mg and/or protein:creatinine ratio (PCR) > 
0.15 (4-7), but have not been prospectively tested.  
Conclusions 
•  12-hr urine protein > 165mg is a good surrogate for 24-hr urine protein 
≥ 300mg with the potential benefit of earlier diagnosis and treatment of 
preeclampsia
•  Protein:creatinine ratio > 0.15 may be most useful as a screening 
tool to rule out 24-hr urine protein ≥ 300mg due to its high negative 
predictive value
•  Applying these results to the management of patients with suspected 
preeclampsia has the potential to:
   -  Improve compliance with outpatient collection
   -  Decrease healthcare costs by decreasing the number of admissions 
and length of admissions
   -  Decrease morbidity by decreasing time to diagnosis
References
1.  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in 
Pregnancy.  Am J Obstet Gynecol 2000;183:S1-S22.
2.  Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse D, Spong C. Pregnancy Hypertension. In: Williams 
Obstetrics. 23nd ed. New York: McGraw-Hill, 2010: Chapter 34.
3.  Diagnosis and Management of Preeclampsia and Eclampsia. ACOG Practice Bulletin No.33. American 
College of Obstetricians and Gynecologists. 2002 
4.  Lindheimer M, Kanter, D. Interpreting abnormal proteinuria in pregnancy: the need for a more 
pathophysiological approach. Obstet Gynecol 2010 Feb; 115(2 Pt 1):365-75.
5.  Rinehart BK, Terrone DA, Larmon JE, Perry KG Jr, Martin RW, Martin JN Jr. A 12-hour urine collection 
accurately assesses proteinuria in the hospitalized hypertensive gravida. J Perinatol 1999;19:556-8.
6.  Adelberg AM, Miller J, Doerzbacher M, Lambers DS. Correlation of quantitative protein measurements in 8-, 
12-, and 24-hour urine samples for the diagnosis of preeclampsia. Am J Obstet Gynecol 2001,185:804-807.
7.  Schubert FP, Abernathy MP. Alternative evaluations of proteinuria in the gravid hypertensive patient. J 
Reprod Med 2006;51:709-714
Methods 
•  Inclusion criteria: All pregnant women > 20 weeks’ gestation admitted 
to the Lehigh Valley Health Network antepartum unit undergoing a 24-
hour urine protein for diagnosis and/or management of preeclampsia 
from 7/1/2010 – 12/31/2011.   
•  Exclusion criteria: Prepregnancy renal disease (defined as 24-hr 
urine protein ≥ 300mg), clinical indication for delivery at the time 
of admission, age<18 or >55, non-english speaking or previous 
enrollment in the study.    
•  Primary outcome: test performance of 12-hr urine protein and PCR to 
predict 24-hr urine protein ≥ 300mg.  
•  PCR, 12-hr urine protein, and 24-hr urine protein were collected on 
each subject. Providers were blinded to the 12-hr and PCR results. 
Care was otherwise routine. Urine collection was initiated at the time of 
admission. Subjects were on modified bedrest.
•  Data were analyzed using STATA 9.2 statistical software. A p-value of < 
0.05 was considered statistically significant. 
•  IRB approved.  
Objective 
To determine the performance of 12-hr urine protein > 165mg and PCR > 
0.15 for predicting 24-hr urine protein ≥ 300mg. 
Results 
Future Studies 
•  Develop and prospectively study a clinical algorithm for the diagnosis 
of preeclampsia incorporating 12-hr urine protein and protein:
creatinine ratio in both the inpatient and outpatient settings
• Correlate these test cutoffs with maternal and fetal outcomes
Weaknesses 
•  Small sample size lacks power to correlate with maternal and fetal 
outcomes
•  May not be generalizable to outpatient setting – uncertain impact of 
hospitalization (diet, sleep pattern, activity)
Strengths 
•  “Real life” study design generalizable to clinical practice
• First study to prospectively test previously generated cutoffs
•  Inpatient setting allowed consistency and compliance with collection 
technique
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Figure 2: 12-hour urine protein vs. 24-hour urine protein Figure 3: ROC for 12-hour urine protein



















Area under ROC curve = 0.8770




























Area under ROC curve = 0.9975
Table 3. Test characteristics of 12-hr urine protein > 165 mg and protein: 
creatinine ratio > 0.15 for the prediction of 24-hr urine protein ≥ 300 mg
           12-hr urine protein >165mg PCR > 0.15
Sensitivity 96 (90-99) 89 (81-94)
Specificity 100 (96-100)* 49 (39-59)
PPV 100 (96-100)* 32 (23-42)
NPV 98 (93-100) 91 (84-96)
Data are in % (95% confidence interval). PCR, protein:creatinine ratio. PPV, positive 
predictive value. NPV, negative predictive value.
*Confidence interval is 97.5%. 
Table 2. Urine collection characteristics by 24 hour urine protein result
           
24-hr protein < 300 mg
(N=62)
24-hr protein ≥ 300 mg
(n=28)
P-value
24-hr urine protein (mg) 175 (90-290) 520 (310-6360) <0.001
24-hr urine volume (ml) 2300 (700-4700) 1825 (600-5100) 0.23
24-hr urine CrCl (ml/min) 153 (59-272) 135 (80-283) 0.51
12-hr urine protein (mg) 70 (40-150) 255 (120-2640) <0.001
12-hr urine volume (ml) 1050 (40-2300) 1050 (300-3050) 0.97
12-hr urine protein > 165mg 0 (0%) 27 (96%) <0.001
Protein:creatinine ratio 0.16 (0.07-0.5) 0.35 (0.14-4.57) <0.001
Protein:creatinine ratio > 0.15 30 (52%) 24 (89%) 0.001
Data are in median (range) or n (%). CrCl, creatinine clearance. 
Table 1. Baseline maternal characteristics by 24 hour urine protein result
           
24-hr protein < 300 mg
(N=62)
24-hr protein ≥ 300 mg
(n=28)
P-value
Maternal age (yrs) 29 (19-42) 30 (19-38) 0.76
Race/Ethnicity
    Caucasian
    Black
    Asian










Private insurance 45 (73%) 20 (71%) 0.91
Multiparous 29 (47%) 20 (71%) 0.03
Multiple gestation 8 (13%) 3 (11%) 0.77
BMI 33.1 (19.5-69.9) 36.4 (25.4-54.9) 0.13
Gestational age (wks) 34.3 (29.9-39.0) 32.8 (24.0-35.4) 0.007
Smoking 13 (21%) 4 (14%) 0.45
Comorbidity (any)*
    cHTN
    gHTN or preeclampsia
    Pregestational diabetes

















    Elevated blood pressure
    Proteinuria
    Symptoms^
    Lab abnormalities
    Fetal growth restriction



















Median SBP during collection 131 (99-165) 136 (105-152) 0.11
Median DBP during collection 76 (53-98) 78 (55-99) 0.41
Data are in median (range) or n (%). BMI, body mass index. *Subject may have more than one. cHTN, 
chronic hypertension. gHTN, gestational hypertension. ^Includes headache, scotomata, abdominal 
pain, and significant weight gain associated with edema. +Includes shortness of breath, seizure of 
uncertain origin, oligohydramnios, visual changes other than scotomata. SBP, systolic blood pressure. 





Figure 1: Summary of Patient Enrollment*
* Due to collection or lab error, some patients did not have results for both 12-hr urine and PCR
